Assessing real-world outcomes in metastatic colorectal cancer with KRASG12C mutation.
Journal of Clinical Oncology(2020)
摘要
e16072Background: The KRASG12C mutation is present in 3% of colorectal cancer and is of particular interest given the recent development of specific targeting drugs. Previous data suggest KRAS (all...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要